Board meeting on Nov 4 to consider Q2 and H1 FY27 results
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Unichem Laboratories has informed the exchanges that its Board of Directors will meet on Wednesday, November 4, 2026, to consider and approve the unaudited financial results, both consolidated and standalone, for the second quarter and six months ended September 30, 2026. The intimation is filed under Regulation 29(1) of SEBI Listing Obligations and Disclosure Requirements. No financial figures are provided in this notice, which is a routine advance disclosure ahead of the upcoming earnings announcement.
Routine procedural filing ahead of Q2FY27 results. Unlikely to move the stock on its own, but marks the date for the upcoming earnings announcement.